Top

Published in:

01-12-2017 | Case report

Alemtuzumab

Alopecia universalis: case report

A 49-year-old man developed alopecia universalis during treatment with alemtuzumab. …

Zimmermann J, et al. Alopecia universalis following alemtuzumab treatment in multiple sclerosis: A barely recognized manifestation of secondary autoimmunity-report of a case and review of the literature. Frontiers in Neurology 8: 569, 30 Oct 2017. Available from: URL: http://doi.org/10.3389/fneur.2017.00569 - GermanyCrossRefPubMedPubMedCentral

Title: Alemtuzumab
Alopecia universalis: case report
Publication date: 01-12-2017
Publisher: Springer International Publishing
Published in: Reactions Weekly / Issue 1/2017
Print ISSN: 0114-9954
Electronic ISSN: 1179-2051
DOI: https://doi.org/10.1007/s40278-017-39302-5